Anti-PD1 antibody enhances the anti-tumor efficacy of MUC1-MBP fusion protein vaccine via increasing Th1, Tc1 activity and decreasing the proportion of MDSC in the B16-MUC1 melanoma mouse model.
第一作者:
Zenan,Zhang
第一单位:
Department of Immunology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
作者:
主题词
动物(Animals);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);癌症疫苗(Cancer Vaccines);细胞系, 肿瘤(Cell Line, Tumor);女(雌)性(Female);人类(Humans);免疫疗法(Immunotherapy);黑色素瘤, 实验性(Melanoma, Experimental);小鼠(Mice);黏蛋白-1(Mucin-1);重组融合蛋白质类(Recombinant Fusion Proteins);皮肤肿瘤(Skin Neoplasms);Th1细胞(Th1 Cells);肿瘤微环境(Tumor Microenvironment);疫苗, 合成(Vaccines, Synthetic)
DOI
10.1016/j.intimp.2021.108173
PMID
34607233
发布时间
2022-03-08
- 浏览3
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文